Business SK bioscience gets approval of Quadrivalent Influenza Vaccine in Indonesia
By Diplomacy Journal Lee Kap-soo SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced on Oct. 23 that the world’s first quadrivalent cell-cultured influenza vaccine, SKYCellflu Quadrivalent prefilled syringe, has been approved by Indonesia’s Food and Drug Agency, BPOM (Badan Pengawas Obat dan Makanan). This marks the first time a domestically developed influenza vaccine has been licensed in Indonesia. Indonesia, the world’s fourth most populous nation with over 280 million people, boasts Southeast Asia’s largest e